Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DUT | P33316 | 5/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8933242 | 0.74 | CRBN (0.41) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL7965647 | 0.70 | ADRA2B (0.40) | CRBNDDB1LMNADUTPKM | |
| SCHEMBL16588800 | 0.70 | MAPK1 (0.40) | ALDH1A1LMNA | |
| SCHEMBL9763767 | 0.70 | CRBN (0.42) | CRBNDUTPKM | |
| SCHEMBL3541014 | 0.70 | CRBN (0.54) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL2181554 | 0.70 | CRBN (0.54) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL4537742 | 0.69 | DUT (0.49) | CRBNALDH1A1LMNADUTPKM | |
| SCHEMBL9707667 | 0.69 | — | — | |
| SCHEMBL25430771 | 0.69 | GPR84 (0.44) | CRBN | |
| SCHEMBL9277788 | 0.67 | CRBN (0.45) | CRBNDDB1ALDH1A1LMNADUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120153078-A | RNA molecules encoding RSV-F and vaccines containing the same | 辉瑞大药厂 | 2025-06-13 | — | — | CN | disclosed |
| US-20250163492-A1 | METHOD FOR GENERATING POPULATION OF LABELED NUCLEIC ACID MOLECULES AND KIT FOR THE METHOD | BGI SHENZHEN (CN) | 2025-05-22 | — | — | US | disclosed |
| US-20250129407-A1 | METHOD FOR GENERATING LABELED NUCLEIC ACID MOLECULAR POPULATION AND KIT THEREOF | BGI SHENZHEN (CN) | 2025-04-24 | — | — | US | disclosed |
| CN-119604304-A | Recombinant RNA molecules comprising an untranslated region or a segment encoding spike protein from the Severe acute respiratory coronavirus 2 Omikovia strain | 葛兰素史克生物有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250059530-A1 | LABELING AND ANALYSIS METHOD FOR SINGLE-CELL NUCLEIC ACID | BGI SHENZHEN (CN) | 2025-02-20 | — | — | US | disclosed |
| CN-119431453-A | Phosphorus (V) based reagent, method for the production thereof, and use thereof for producing stereoregular organic phosphorus (V) compounds | 百时美施贵宝公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119375375-A | Method for detecting nucleotide, cap analogue and nucleic acid in vitro transcription product | 楷拓生物科技(苏州)有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118955655-A | GE protein antigen variant, preparation method and application thereof | 北京微星生物科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-4455299-A1 | METHOD FOR GENERATING LABELED NUCLEIC ACID MOLECULAR POPULATION AND KIT THEREOF | BGI Shenzhen (CN) | 2024-10-30 | — | — | EP | disclosed |
| EP-4455306-A1 | LABELING AND ANALYSIS METHOD FOR SINGLE-CELL NUCLEIC ACID | BGI Shenzhen (CN) | 2024-10-30 | — | — | EP | disclosed |
| CN-114015755-A | Method and kit for labeling nucleic acid molecules | 中国科学院北京基因组研究所(国家生物信息中心) | 2022-02-08 | — | — | CN | disclosed |
| CN-108430456-B | Cancer vaccine | 摩登纳特斯有限公司 | 2022-01-18 | — | — | CN | disclosed |
| WO-2021202557-A1 | SPHERICAL NUCLEIC ACIDS (SNAS) FOR REGULATION OF FRATAXIN | EXICURE OPERATING COMPANY (US) | 2021-10-07 | — | — | WO | disclosed |
| CN-112996854-A | High purity PEG lipids and uses thereof | 摩登纳特斯有限公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-112236438-A | Novel phosphorus (V) -based reagents, method for the production thereof, and use thereof for producing sterically defined organic phosphorus (V) compounds | 百时美施贵宝公司 | 2021-01-15 | — | — | CN | disclosed |
| WO-2018170270-A1 | VARICELLA ZOSTER VIRUS (VZV) VACCINE | MODERNATX, INC. (US) | 2018-09-20 | — | — | WO | disclosed |
| EP-3204499-A1 | ANTI-TNF COMPOUNDS | Exicure, Inc. (US) | 2017-08-16 | — | — | EP | disclosed |
| WO-2016057549-A1 | ANTI-TNF COMPOUNDS | AURASENSE THERAPEUTICS, LLC (US) | 2016-04-14 | — | — | WO | disclosed |
| WO-2014183023-A1 | USING PLEXIN-A4 AS A BIOMARKER AND THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2014-11-13 | — | — | WO | disclosed |
| US-7838270-B2 | Target-dependent transcription using deletion mutants of N4 RNA polymerase | THE UNIVERSITY OF CHICAGO (US) | 2010-11-23 | — | — | US | disclosed |